KR20160007678A - Blood Glucose Information Providing System and Method - Google Patents

Blood Glucose Information Providing System and Method Download PDF

Info

Publication number
KR20160007678A
KR20160007678A KR1020160000073A KR20160000073A KR20160007678A KR 20160007678 A KR20160007678 A KR 20160007678A KR 1020160000073 A KR1020160000073 A KR 1020160000073A KR 20160000073 A KR20160000073 A KR 20160000073A KR 20160007678 A KR20160007678 A KR 20160007678A
Authority
KR
South Korea
Prior art keywords
blood glucose
information
user
exercise
glucose measurement
Prior art date
Application number
KR1020160000073A
Other languages
Korean (ko)
Inventor
강수진
Original Assignee
강수진
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 강수진 filed Critical 강수진
Priority to KR1020160000073A priority Critical patent/KR20160007678A/en
Publication of KR20160007678A publication Critical patent/KR20160007678A/en

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
    • A61B5/6898—Portable consumer electronic devices, e.g. music players, telephones, tablet computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
    • G06F19/34—
    • G06F19/3456—
    • G06F19/3475—
    • G06F19/3481—
    • G06F19/363—

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • Multimedia (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

The objective of the present invention is to measure blood glucose non-invasively and easily, to provide various blood glucose information on the basis of information of a user, and to conveniently manage the blood glucose of the user by delivering medical information of the user to a protector of the user. In a method for providing diabetes and blood glucose information, the method includes: a step in which a terminal receives blood glucose measurement information of the user periodically; a step in which an input part of the terminal receives insulin administration information, food ingestion information, exercise information and activity information; a step in which a memory part of the terminal stores the blood glucose measurement information and the insulin administration information, the food ingestion information, the exercise information and the activity information by the input part; a step in which a control part of the terminal calculates blood glucose management information on the basis of the information stored in the memory part; and a step in which a display part of the terminal displays the blood glucose management information calculated by the control part.

Description

[0001] Description [0002] Blood Glucose Information Providing System and Method [

The present invention relates to a system and a method for providing diabetic blood glucose information by measuring the blood glucose of a user and providing the user with insulin administration and food intake information.

Recently, living environment has improved and interest in personal health has been increasing. Accordingly, various medical devices that can easily check the health condition of the individual are being developed, and the medical environment is also changing. For example, a medical device that can easily check the health condition of the user himself or herself without having to go to a hospital has been developed and spread.

In particular, the number of diabetic patients is rapidly increasing in Hyundai, and attention and development of blood glucose control medical devices are concentrated. The normal blood sugar level is about 80mg / dl before the meal and 120mg / dl after the meal. In order to maintain the blood glucose level, the living body needs to secrete a proper amount of insulin from the pancreas before or after the meal to be absorbed into liver and skeletal muscle cells. do. However, when insulin is not produced from the pancreas as needed to maintain normal blood glucose due to a disease or other cause, an excessive amount of glucose is present in the blood, which causes heart and liver diseases, arteriosclerosis, hypertension, , Retinal hemorrhage, nerve damage, hearing loss, or visual loss may occur and may result in severe death.

Type 1 diabetes, which is known to be an adult disease but does not have any insulin in the pancreas, is increasing worldwide as children with diabetes are called 'child diabetes'. Children with diabetes require injections of insulin at least four times a day and blood tests at least seven times a day. If the blood sugar level falls suddenly and complications can come, so you should take the time of inspections and the time of insulin administration. However, according to the Korean Diabetes Association, only 36.4% of patients in the nursing home receive insulin injections, and 30.3% of children with diabetes mellitus secretly use insulin in the bathroom. One in three children with diabetes is tested for blood sugar alone without the help of a friend or teacher and is given an insulin injection in the bathroom.

Because insulin is a protein, if you take it as a pill, you will be able to digest it by inserting it into your blood before it lowers your blood sugar. So insulin is supplied through injections.

The reason why we need to measure blood sugar is because the blood glucose level varies with time due to various causes such as food intake. In the fasting state, the longer the time without food consumption, the lower the blood glucose level, and the higher the blood glucose level, the more food is consumed. Therefore, it is necessary to measure the blood glucose level several times a day to grasp the accurate blood glucose level. It is a great burden for users, especially children, to measure blood glucose levels several times a day. It is also very difficult to determine the appropriate dosage of insulin according to the measured blood glucose level.

Therefore, there is a need to develop a technique that can easily measure blood glucose in a non-invasive manner, reduce insulin burden by providing users with insulin administration and food intake information, and transmit the user's medical information to the user's caregiver.

Patent Registration No. 10-1564066 (registered on October 22, 2015) Published Patent Publication No. 10-2008-0072158 (Published on August 8, 2008)

Disclosure of Invention Technical Problem [8] Accordingly, the present invention has been made to solve the above-mentioned problems occurring in the prior art, and it is an object of the present invention to provide a blood glucose analyzer, So that it can be conveniently managed.

The present invention also has a purpose of informing the user of the kind and amount of insulin necessary for administration and the administration time so as to stably manage blood glucose.

It is an object of the present invention to provide information on a food intake amount and an exercise amount necessary for a user based on blood glucose information of a user.

It is to be understood that the present invention is not limited to the above-mentioned problems, and other problems not mentioned may be clearly understood by those skilled in the art to which the present invention belongs There will be.

In order to accomplish the above-mentioned object, a representative configuration of the present invention is as follows.

According to an embodiment of the present invention, a method for providing diabetic glucose information is provided. A method for providing diabetic blood glucose information comprises: transmitting non-invasive blood glucose measurement apparatus information of a user's blood glucose measurement periodically to a terminal; Wherein the input unit of the terminal receives insulin administration information, food intake information, exercise information, and activity information; The memory unit of the terminal may store blood glucose measurement information, insulin administration information, food consumption information, exercise information, and activity information of a user; The control unit of the terminal calculates blood glucose management information based on the information stored in the memory unit; The display unit of the terminal may be configured to display the blood glucose management information calculated by the controller.

Here, the blood glucose measurement information means the blood glucose measurement value and the measurement time. In addition, blood glucose management information includes blood glucose level change by exercise / activity, blood glucose level change according to daily time, blood glucose predicted value, type of insulin needed for administration, dosage and administration time, recommended amount of food intake and intake time, And a message warning that the target value is out of the range. And activity information means information about reading a book, viewing a television, watching a movie, and the like.

According to an embodiment of the present invention, the method for providing diabetic blood glucose information may further include periodically displaying a request for inputting insulin administration information, food intake information, exercise information, and activity information.

According to an embodiment of the present invention, the method for providing diabetic blood glucose information may further include transmitting the necessary amount of insulin, the administration time, the recommended amount of food intake, and the time of consumption to a cellular phone owned by the caregiver of the user.

According to an embodiment of the present invention, a method for providing diabetic blood glucose information includes calculating a blood glucose level change according to a user's activity, a blood glucose level change trend according to daily time, a blood glucose predicted value, a required insulin dose and administration time, a recommended amount of food intake, The steps can be configured to analyze based on the user's past case.

According to an embodiment of the present invention, a diabetes blood glucose information providing system is provided.

Wherein the non-invasive blood glucose measuring device comprises a non-invasive blood glucose measuring device and a terminal, the non-invasive blood glucose measuring device measures the blood glucose of the user by non-invasive method and periodically transmits the blood glucose measurement information to the terminal, An input unit for inputting the blood glucose measurement information from the non-invasive blood glucose measurement apparatus, an input unit for inputting insulin administration information, food intake information, exercise information, activity information, and information transmitted from the non-invasive blood glucose measurement apparatus A memory unit for storing the blood glucose measurement information received by the user, a control unit for calculating the blood glucose management information of the user based on the information stored in the memory unit, and transmitting the blood glucose management information to the display unit, .

According to an embodiment of the present invention, the diabetes blood glucose information providing system may further include the terminal that transmits the necessary amount of insulin, the administration time, the recommended amount of food intake, and the time of consumption to a cellular phone owned by the caregiver of the user .

In addition, the apparatus and method for providing diabetic blood glucose information according to the present invention may further include other additional configurations as long as the technical idea of the present invention is not adversely affected.

According to the present invention, a user can easily measure blood sugar and can conveniently obtain various information such as an insulin dosage and administration time necessary for administration, necessity of intake of emergency food, change in blood glucose according to exercise or activity, And the user's caregiver can also be provided with information necessary for the user's blood sugar-related measures.

FIG. 1 schematically shows a conventional noninvasive blood glucose measurement device.
2 shows a terminal according to a temporal example of the present invention.
FIG. 3 shows a terminal according to a temporal example of the present invention.
FIG. 4 shows an example of blood glucose measurement information of a user.
Figure 5 shows a blood glucose control procedure using the correlation between insulin administration, food intake, and exercise.
6 shows an example of a change in blood glucose level before and after the ingestion of food.
FIG. 7 shows a step of calculating an insulin type, a dose, and an administration time required for pre-food intake.
FIG. 8 shows prediction of change in blood glucose level due to exercise or activity.
Fig. 9 shows a configuration for transmitting a warning message.

Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings so that those skilled in the art can easily carry out the present invention.

In order to clearly explain the present invention, a detailed description of parts that are not related to the present invention will be omitted, and the same constituent elements will be denoted by the same reference numerals throughout the entire specification. In addition, since the shapes and sizes of the respective components shown in the drawings are arbitrarily shown for convenience of explanation, the present invention is not necessarily limited to the illustrated shapes and sizes. That is, the specific shapes, structures, and characteristics described in the specification may be modified and embodied from one embodiment to another without departing from the spirit and scope of the present invention. Also, It is to be understood that changes may be made without departing from the spirit and scope of the invention. Therefore, the following detailed description is not intended to be construed in a limiting sense, and the scope of the present invention should be construed as encompassing the scope of the appended claims and all equivalents thereof.

Non-invasive blood glucose measuring device

FIG. 1 shows a non-invasive blood glucose measurement device developed in the prior art disclosed in Published Unexamined Patent Application No. 10-2008-0072158. The non-invasive blood glucose measuring apparatus shown in FIG. 1 includes a tissue modulating unit for applying pressure to a tissue; A hemoglobin measuring unit for measuring a hemoglobin concentration of the tissue by analyzing the degree of absorption of electromagnetic waves in the first region of the tissue before and after the pressure is applied in the tissue modulating unit; And applying pulse laser light to the second portion of the tissue before and after applying the pressure in the tissue modulating portion to measure a blood glucose concentration by analyzing a photoacoustic signal generated from the tissue, And a photoacoustic module unit for measuring the final blood glucose level by correcting the measured blood glucose concentration according to the hemoglobin concentration.

In other non-invasive blood glucose measurement methods, glucose is collected on the skin by applying an electric current to the skin, and light is irradiated to the skin portion where glucose is collected to receive light reflected or scattered at the glucose-captured portion. The concentration of glucose can be measured by the spectrum obtained from the received light.

Non-invasive blood glucose measuring device can measure blood glucose more easily than blood glucose measuring device and it can periodically measure automatically after attaching to skin. For accurate blood glucose control, it is desirable to measure blood glucose at least once per hour.

terminal

2 shows a terminal 100 according to a temporal example of the present invention.

The terminal includes a transmission / reception unit 105, an input unit 102, a memory unit 103, a control unit 101, and a display unit 104.

The transceiver unit 105 communicates with the non-invasive blood glucose measurement apparatus via wireless or wire to receive blood glucose measurement information. The input unit 102 receives insulin administration information, food intake information, exercise information, and activity information. The memory unit stores the information input by the input unit and the blood glucose measurement information transmitted from the non-invasive blood glucose measurement apparatus. The control unit calculates the blood glucose management information of the user based on the information stored in the memory unit and transmits the information to the display unit. The display unit receives and displays the blood glucose management information of the user from the control unit.

Methods for diagnosing diabetes include fasting plasma glucose, randomized blood glucose test, oral glucose tolerance test, and glycated hemoglobin test. Generally, fasting blood glucose is the blood glucose level measured without taking food or drink for 8 to 12 hours or more. Normal fasting diabetic level is normal, not exceeding 100 mg / dL, and diabetes is diagnosed when it exceeds 126 mg / dL. A randomized blood glucose test is a test that can be taken at any time regardless of whether food is consumed or not. It is a case of hyperglycemia with a level of more than 200 mg / dL or a symptom of diabetes with hyperglycemia (increased urine volume, frequent thirst, Diarrhea, diarrhea, diarrhea, diarrhea, diarrhea, abdominal pain, diarrhea, Oral glucose tolerance test is a test to measure blood glucose after 3 hours after drinking 75 g of specific glucose and is more than 200 mg / dL. The glycated hemoglobin test measures the average level of glucose in the blood between two months or three months. It can be measured at any time before and after ingestion of food, and is diagnosed as diabetes if 4-6% is normal and 6.5% .

FIG. 3 shows a terminal according to a temporal example of the present invention.

FIG. 2 shows a temporal example in which the terminal and the non-invasive blood glucose measurement device are separately configured. However, the non-invasive blood glucose measurement device may be embedded in the terminal, do. Here, the measurement unit 106 may be a non-invasive blood glucose measurement device or a blood glucose measurement device.

FIG. 4 shows an example of blood glucose measurement information of a user.

There are generally five types of insulin. First, fast-acting insulin lispro (Humalog, hiragogi) begins to work within 5 to 15 minutes after injection, reducing blood sugar to a maximum of 45 to 90 minutes after injection and effective for 3 to 4 hours after injection. The second is the fast acting insulin, which starts to work within 30 minutes after injection and reduces blood sugar to maximum within 2 to 5 hours after injection and is effective for 5 to 8 hours after injection. Third, intermediate rate, NPH or lent insulin begins to act within 1 to 3 hours after injection, and the blood sugar level is lowered to within 6 to 12 hours after injection, and the effect continues until 16 to 24 hours after injection. Fourth, persistent ultra-lutein insulin begins to act within 4 to 6 hours after injection and decreases blood sugar to maximum within 8 to 20 hours after injection and is effective until 24 to 28 hours after injection. Finally, with NPH and regular insulin, the duration of action is within 30 minutes of injection and within 7 to 12 hours after injection, blood glucose is lowered to the maximum and the action is continued for 16 to 24 hours after injection. Therefore, it is preferable to use insulin suitable for the diabetic type of the user, change in blood glucose level, and the like.

FIG. 5 shows blood glucose control using the correlation between insulin administration, food intake, and exercise.

First, a method of providing diabetic blood glucose information according to morning blood glucose measurement values will be described. The control unit sets the blood glucose target range value for breakfast. For example, a blood glucose level of 100-120 mg / dL, which is a normal person's blood glucose level, is set as the blood glucose target range value. The blood glucose target range value may be input through the input unit and variously set. The control unit determines whether the received morning blood glucose measurement value is higher than the blood glucose target range position. If the pre-breakfast blood glucose measurement value is higher than the target blood glucose range, the control unit determines whether the blood glucose target blood glucose level exceeding the target blood glucose level is a persistent phenomenon. For example, if the blood glucose measurement value continuously exceeds the blood glucose target range for two or more consecutive days, it is determined that the phenomenon is continuous, and the control unit displays a message to increase the insulin dose before breakfast. However, if the amount of food consumed or the amount of exercise is low on the previous day, the control unit may suspend the judgment that it is a continuous phenomenon based on the food intake information, the exercise information, and the activity information input through the input unit, Keep your insulin dosage at the same level, increase your exercise and reduce your food intake.

If the pre-breakfast blood glucose measurement is lower than the target blood glucose range, the control unit displays the indication of the emergency food intake through the display unit. Here, emergency food is a food that increases blood sugar so that the user can quickly get out of hypoglycemia. The control unit determines whether or not the blood glucose measurement value falls below the target blood glucose level is a continuous phenomenon. For example, if the blood glucose level is below the target blood glucose level continuously for more than 2 days, it is determined that the blood glucose level is continuously maintained, and the control unit displays a message to reduce the insulin dose before breakfast. However, if the amount of food intake is small or the amount of exercise is large on the previous day, the control unit suspends the determination that the food is a continuous phenomenon based on the food intake information, exercise information, and activity information input through the input unit, Keep the insulin dosage at the same level, reduce exercise, and increase food intake.

If the pre-breakfast blood glucose measurement is within the target range of blood glucose, the control unit displays the insulin dose before breakfast to be maintained through the display unit.

6 shows an example of a change in blood glucose level before and after the ingestion of food.

It is necessary to control the blood glucose level by administering insulin when the blood glucose level rises abnormally when the blood glucose level rises generally after the ingestion of food. Because insulin has many different kinds of insulin, the start time, the maximum action time, and the effect duration vary depending on the type of insulin.

FIG. 7 shows a step of calculating an insulin type, a dose, and an administration time required for pre-food intake.

The memory unit continuously stores and stores the blood glucose measurement information before and after the user's food intake, the kind of insulin, the dose, and the time of administration.

The control unit receives the current blood glucose measurement value of the user before the consumption of food through the transmission / reception unit 105. The control unit extracts the blood glucose measurement values of the user having a difference within 5% from the received current blood glucose measurement value If there is no case in judgment 1, extracting cases of blood glucose measurement values of a user whose difference is within 10% from the received current blood glucose measurement value in judgment 2 from the memory part; In the case where there is a case, a case is selected in which the postprandial blood glucose level is within the target range of blood glucose level from the extracted cases in the judgment 3, and in the case of the case selected in the judgment 3, the type of insulin administered in the selected case Calculating the average of the dose and the administration time, calculating the type of insulin, the dose of insulin and the administration time It includes a step of transmitting to the display. If there is no case selected in decision 3, the step 4 further includes a step of transmitting the dose and the administration time to the display unit for each type of insulin administered in the case where the postprandial blood glucose level is closest to the target blood glucose level. If there is no example of blood glucose measurement of a user having a difference of 10% or less from the current blood glucose measurement value transmitted in the memory unit in decision 2, the process further proceeds to step 4.

The display unit displays the type of insulin received from the control unit and the calculated dosage and administration time of insulin.

FIG. 8 shows prediction of change in blood glucose level due to exercise or activity.

The memory unit continuously accumulates and stores changes in blood glucose measurement values before and after the exercise or activity according to the user's exercise or activity type.

The control unit receives the type of exercise or activity to be performed by the user through the input unit, receives a case corresponding to the exercise or activity to be performed by the user from the memory unit, and transmits the current blood glucose measurement value A step of extracting cases of blood glucose measurement of a user having a difference of less than 5% from the received current blood glucose measurement value among the cases received from the memory unit in the decision a, b) extracting cases of blood glucose measurement values of a user having a difference of 10% or less from the received current blood glucose measurement value among the cases received from the memory unit, and if there is a corresponding case in decision a or decision b, Calculating an average value of blood glucose levels measured after exercise or after exercise from the cases, It includes a step of transmitting after exercise or activity measured blood glucose level to the display in blood glucose estimate. If there is no case where the difference is within 10% of the current blood glucose measurement value transmitted from the memory unit in decision b, an average value of the blood glucose level change measured before and after the exercise or activity received in the memory unit is calculated. And transmitting the calculated blood glucose level to the display unit based on an average value of blood glucose level changes measured before and after the activity. Here, the expected blood glucose value is obtained according to the following formula.

Estimated blood glucose = (current blood glucose level before exercise or activity) - (average blood glucose level before and after exercise or activity)

The control unit transmits a warning message through the display unit when the estimated blood glucose level is lower than the target blood glucose level.

Fig. 9 shows a configuration for transmitting a warning message.

The control unit transmits a warning message to the user through the display unit if the current blood glucose measurement value or the blood glucose estimation value is outside the blood glucose target value range. Further, the control unit transmits a warning message to the user's guardian terminal through the transmitting / receiving unit.

While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed exemplary embodiments, but, on the contrary, Those skilled in the art will appreciate that various modifications and changes may be made thereto without departing from the scope of the present invention.

Therefore, the spirit of the present invention should not be construed as being limited to the above-described embodiments, and all the equivalents or equivalents of the claims are to be construed as falling within the scope of the present invention.

The present invention relates to a pulse laser diode (LD) light source unit 321, a pulse laser diode (LD) light source unit 323, a pulse laser diode (LD) light source unit 323, : Photoacoustic signal detecting unit 325: blood glucose concentration calculating unit 330: Hb (hemoglobin) measuring unit 331: light source array 332: optical sensor 333: hemoglobin concentration calculating unit

Claims (10)

A method for providing diabetic blood glucose information, the method comprising: periodically receiving input information of blood sugar measurement by a terminal; Wherein the input unit of the terminal receives insulin administration information, food intake information, exercise information, and activity information; The memory unit of the terminal stores the blood glucose measurement information and the insulin administration information, the food intake information, the exercise information, and the activity information by the input unit; The control unit of the terminal calculates blood glucose management information based on the information stored in the memory unit; Wherein the display unit of the terminal displays the blood glucose management information calculated by the controller [6] The method of claim 1, wherein the step of receiving the blood glucose measurement information of the terminal further comprises transmitting the blood glucose measurement information of the user to the transceiving unit of the terminal by the non-invasive blood glucose measurement apparatus configured separately from the terminal How to provide diabetes blood glucose information The method according to claim 1, wherein the step of receiving the blood glucose measurement information of the user by the terminal further comprises the step of acquiring the blood glucose measurement information of the user of the terminal and transmitting the information to the controller The method of claim 1 or 2, further comprising the steps of: setting a blood glucose target range value through the input unit in order to provide diabetic blood glucose information according to blood glucose measurement values in the morning, Determining whether the current blood glucose measurement value is higher than the target blood glucose level, if the current blood glucose measurement value is higher than the blood glucose target range position, , The control unit displays a message to increase the insulin dose through the display unit; However, if the amount of food consumed or the amount of exercise is small on the previous day, the control unit may determine that the food is a continuous phenomenon based on the food intake information, the exercise information, and the activity information input through the input unit, Displaying a message indicating that the insulin dose is kept the same and the exercise amount is increased and the food intake amount is decreased through the display unit; Wherein the control unit displays the current blood glucose measurement value through the display unit when the current blood glucose measurement value is lower than the target blood glucose range position, A step of determining that the insulin dose is continuously decreased, and the control unit displaying a content of decreasing the insulin dose through the display unit; However, the control unit reserves a judgment that if the amount of food intake is small or the exercise amount is large, the control unit determines that it is a continuous phenomenon based on the food intake information, the exercise information, and the activity information input through the input unit, Further comprising the step of displaying a message to reduce the amount of exercise and to increase the amount of food intake by maintaining the same amount of insulin dose through the display unit The method according to claim 1 or 2, wherein the step of calculating blood glucose management information comprises the steps of extracting, from the memory unit, cases of blood glucose measurement values of a user whose difference is within 5% If there is no case in Judgment 1, a case where a case of a blood glucose measurement value of a user whose difference is within 10% with the current blood glucose measurement value in Judgment 2 is extracted from the memory unit; In Case 3, the cases where the postprandial blood glucose level is within the blood glucose target range are selected from the extracted cases, and in the case where there is a case selected in the judgment 3, the dosage and administration amount according to the type of insulin administered in the selected case Calculating the average value of the time, calculating the dose and the administration time of the insulin calculated according to the kind of the insulin, Comprising the step of transmitting portion, and; If there is no case selected in decision 3, the method further includes a step of transmitting the dose and the administration time to the display unit for each type of insulin administered in the case where the postprandial blood glucose level is closest to the target blood glucose level in decision 4; And if the user does not have a blood sugar measurement value in a memory part that is different from the current blood glucose measurement value by 10% in decision 2, the process further proceeds to step 4 The method according to claim 1 or 2, wherein the control unit further comprises calculating an expectation value of blood glucose according to exercise or activity, wherein the control unit receives a movement or an activity type to be input by the user through the input unit A process of receiving a case corresponding to an exercise or an activity to be performed by the user from the memory unit, a process of determining whether a user who is within 5% of the current blood glucose measurement value of the current blood glucose measurement information among the cases received from the memory unit, A step of extracting cases of blood glucose measurement values of a user having a difference within 10% among the cases received from the memory unit in the determination b, if there is no case to be extracted in the determination a, Or if there is a corresponding case in decision b, Calculating a mean value of the measured blood glucose levels after the exercise, and transmitting the measured blood glucose level after the exercise or activity to the display unit using the estimated blood glucose level; If there is no case where the difference is within 10% in the memory unit in decision b, an average value of changes in blood glucose level measured before and after the exercise or activity received in the memory unit is calculated, and the blood glucose value measured before / (Estimated blood glucose level = (blood glucose level before exercise or activity before exercise) - (average value of change in blood glucose level measured before and after exercise or activity)) by subtracting the average blood glucose level change value How to provide diabetes blood glucose information The method according to claim 1 or 2, wherein the control unit further comprises a step of transmitting a warning message to a cell phone owned by the guardian of the user when the current blood glucose measurement value of the current blood glucose measurement information is lower than the target blood glucose level, Delivery method The method according to claim 1 or 2, wherein the control unit further comprises a step of transmitting the blood glucose management information to a cellular phone owned by a user's caregiver [7] The method of claim 6, wherein the control unit further includes a step of transmitting a warning message to a cell phone owned by the guardian of the user when the estimated blood glucose level is lower than the target blood glucose level Wherein the non-invasive blood glucose measuring device comprises a non-invasive blood glucose measuring device and a terminal, the non-invasive blood glucose measuring device measures the blood glucose of the user by non-invasive method and periodically transmits the blood glucose measurement information to the terminal, An input unit for inputting the blood glucose measurement information from the non-invasive blood glucose measurement apparatus, an input unit for inputting insulin administration information, food intake information, exercise information, activity information, and information transmitted from the non-invasive blood glucose measurement apparatus A memory unit for storing the blood glucose measurement information received by the user, a control unit for calculating the blood glucose management information of the user based on the information stored in the memory unit, and transmitting the blood glucose management information to the display unit, A diabetic blood glucose information providing system
KR1020160000073A 2016-01-02 2016-01-02 Blood Glucose Information Providing System and Method KR20160007678A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160000073A KR20160007678A (en) 2016-01-02 2016-01-02 Blood Glucose Information Providing System and Method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160000073A KR20160007678A (en) 2016-01-02 2016-01-02 Blood Glucose Information Providing System and Method

Publications (1)

Publication Number Publication Date
KR20160007678A true KR20160007678A (en) 2016-01-20

Family

ID=55308099

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160000073A KR20160007678A (en) 2016-01-02 2016-01-02 Blood Glucose Information Providing System and Method

Country Status (1)

Country Link
KR (1) KR20160007678A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109620252A (en) * 2018-12-29 2019-04-16 孙成林 A kind of blood glucose monitoring system and method
KR20200142380A (en) * 2019-06-12 2020-12-22 이오플로우(주) Method for managing disbetes through user terminal
US11058358B2 (en) 2017-10-17 2021-07-13 Samsung Electronics Co., Ltd. Apparatus and method for correcting error of bio-information sensor, and apparatus and method for estimating bio-information

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080072158A (en) 2007-02-01 2008-08-06 삼성전자주식회사 Noninvasive apparatus and method for measuring blood glucose
KR101564066B1 (en) 2015-05-29 2015-10-29 주식회사 휴이노 Bio-signal measuring device differently operated according to counter parts

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080072158A (en) 2007-02-01 2008-08-06 삼성전자주식회사 Noninvasive apparatus and method for measuring blood glucose
KR101564066B1 (en) 2015-05-29 2015-10-29 주식회사 휴이노 Bio-signal measuring device differently operated according to counter parts

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11058358B2 (en) 2017-10-17 2021-07-13 Samsung Electronics Co., Ltd. Apparatus and method for correcting error of bio-information sensor, and apparatus and method for estimating bio-information
US11642086B2 (en) 2017-10-17 2023-05-09 Samsung Electronics Co., Ltd. Apparatus and method for correcting error of bio-information sensor, and apparatus and method for estimating bio-information
CN109620252A (en) * 2018-12-29 2019-04-16 孙成林 A kind of blood glucose monitoring system and method
KR20200142380A (en) * 2019-06-12 2020-12-22 이오플로우(주) Method for managing disbetes through user terminal
WO2020251251A3 (en) * 2019-06-12 2021-05-20 이오플로우(주) User terminal and method for managing status through user terminal after automatically injecting medication
KR20220019743A (en) * 2019-06-12 2022-02-17 이오플로우(주) Method for managing disbetes through user terminal

Similar Documents

Publication Publication Date Title
Zaharieva et al. Lag time remains with newer real-time continuous glucose monitoring technology during aerobic exercise in adults living with type 1 diabetes
Klonoff Continuous glucose monitoring: roadmap for 21st century diabetes therapy
ES2656212T3 (en) System for the detection and control of hypoglycemia
JP3594897B2 (en) Extrapolation system for glucose concentration
EP2217135B1 (en) Assessing residual insulin time
Weiss et al. Noninvasive continuous glucose monitoring using photoacoustic technology—results from the first 62 subjects
WO2005112740A2 (en) Noninvasive glucose sensor
CA2547871A1 (en) Method and device for assessment of a series of glucose concentration values of a body fluid of a diabetic for adjustment of insulin dosing
Benhamou et al. Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE.
US11992310B2 (en) Personal health monitoring system, multiple user health monitoring system, and method
JPH1156822A (en) Blood sugar measuring instrument
KR20160007678A (en) Blood Glucose Information Providing System and Method
WO2006097933A2 (en) Method for monitoring changes in blood glucose level
Block et al. Minimally-invasive and non-invasive continuous glucose monitoring systems: Indications, advantages, limitations and clinical aspects
Battelino et al. Clinical use of real-time continuous glucose monitoring
CN115337502A (en) Blood glucose monitoring and controlling system and blood glucose monitoring and controlling method
Horman et al. Performance and User Experience Evaluation of a Non Invasive Glucose Monitoring Device
KR20170056904A (en) Insulin Suppliment System using Continous Glucose Measuremrnt System
Jung et al. Design of automatic insulin injection system with Continuous Glucose Monitoring (CGM) signals
Weinzimer et al. Continuous glucose monitoring in type 1 diabetes
US20230270362A1 (en) Continuous health monitoring system
Distiller Should all patients on insulin be using continuous glucose monitoring?
Panwar et al. Non-invasive Blood Glucose Estimation Methodology Using Predictive Glucose Homeostasis Models
Jenkins et al. Type 1 Diabetes Glucose Control related Home-Based Testing: A Mini-Review of Tools and Patient Knowledge and Implementation
MALTONI SECTION 1 CHAPTER 3 GLUCOSE MONITORING: SBGM, CGM, FGM

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application
E601 Decision to refuse application